Efficacy of recurrent transcutaneous magnetic stimulation in the treatment of diabetic peripheral neuropathy: Multicenter randomized trial
Pain Practice · 2023
DOI: 10.1111/papr.13269 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Pain Practice, 2023. Verfasst von Vishnu P Rao und 4 weiteren Autor:innen. Beteiligte Einrichtung: University of Maryland, School of Medicine, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Diabetic Neuropathies, Diabetes Mellitus. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Aims
Transcutaneous magnetic stimulation (TCMS) is successful in decreasing pain in several neurologic conditions. This multicenter parallel double‐blind phase II clinical trial is a follow‐up to a pilot study that demonstrated pain relief in patients with diabetic peripheral neuropathy (DPN) treated with TCMS.
Methods
Thirty‐four participants with confirmed DPN and baseline pain score ≥ 5 were randomized to treatment at two sites. Participants were treated with either TCMS ( n = 18) or sham ( n = 16) applied to each foot once a week for four weeks. Pain scores using the Numeric Pain Rating Scale after 10 steps on a hard floor surface and answers to Patient‐Reported Outcomes Measurement Information System pain questions were recorded by participants daily for 28 days.
Results
Thirty‐one participants completed the study and were analyzed. Average pain scores decreased from baseline in both the groups. The difference in pain scores between TCMS and sham treatments was −0.55 for morning, −0.13 for evening, and −0.34 overall, below the pre‐determined clinically relevant difference of −2. Moderate adverse events that resolved spontaneously were experienced in both treatment arms.
Conclusion
In this two‐arm trial, TCMS failed to demonstrate a significant benefit over sham in patient reported pain suggesting a substantial placebo effect in our previous pilot study.
Trial registration
TCMS for the Treatment of Foot Pain Caused By Diabetic Neuropathy, https://clinicaltrials.gov/ct2/show/NCT03596203 , ID‐NCT03596203.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University of Maryland, School of Medicine, Baltimore, Maryland, USA.
- Division of Endocrinology, Diabetes and Nutrition, University of Maryland School of Medicine, Baltimore, Maryland, USA.
- Rosalind Franklin University of Medicine and Science Medical Sciences, North Chicago, Illinois, USA.
- MedStar Medical Group, Baltimore, Maryland, USA.
ORCID-Profile: Kashif M Munir
Förderung
- NIDDK NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Rao, V. P., Kim, Y. K., Ghazi, A., Park, J. Y., & Munir, K. M. (2023). Efficacy of recurrent transcutaneous magnetic stimulation in the treatment of diabetic peripheral neuropathy: Multicenter randomized trial. Pain Practice. https://doi.org/10.1111/papr.13269
Vancouver
Rao VP, Kim YK, Ghazi A, Park JY, Munir KM. Efficacy of recurrent transcutaneous magnetic stimulation in the treatment of diabetic peripheral neuropathy: Multicenter randomized trial. Pain Practice. 2023. doi:10.1111/papr.13269
BibTeX
@article{Rao2023,
author = {Rao, Vishnu P and Kim, Yoon Kook and Ghazi, Anahita and Park, Jean Y and Munir, Kashif M},
title = {Efficacy of recurrent transcutaneous magnetic stimulation in the treatment of diabetic peripheral neuropathy: Multicenter randomized trial},
journal = {Pain Practice},
year = {2023},
doi = {10.1111/papr.13269}
}
EUVIMED